
It's products will target neurological diseases such as epilepsy, schizophrenia, autism and Alzheimer’s.

Parky App monitors symptoms such as tremors and dyskinesia in real-time via the use of the Apple Watch.

Seeking DNA and health histories from 10,000 people, the enormous dataset is expected to assist researchers for decades.

Europe’s largest provider of digital-first home healthcare, Cera, is further investing in its technology and data insights as winter approaches. Cera, a digital-first home healthcare company...

The acquisition of Hospice Corporation of America by Kain Capital’s PERA Holdings serves as a foundation for the firm’s investment strategy in the hospice and palliative...

A new artificial intelligence blood testing technology has been shown to detect more than 80 per cent of liver cancers in a new study. A novel...

Researchers behind a new study in the US, say some commercial wireless earbuds, such as Apple AirPods can perform as well as hearing aids. The findings,...

The dual-mode brain-sensing device can detect Alzheimer’s disease (AD) quickly and effectively.

The company plans to utilise its proprietary Brain Transporter technology

Researchers are working on identifying immune deficits that are associated with the development of the disease.